The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approaches

INTRODUCTION: Low‐grade gliomas (LGGs) are currently considered a premalignant condition for high‐grade gliomas (HGGs) and are characterized by a relatively intact immune system. Immunotherapeutic modalities may offer a safe and effective treatment option for these patients. However, the CD2–CD58 ax...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Mingwei, Chen, Yiyuan, Hua, Gao, Chunhui, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571499/
https://www.ncbi.nlm.nih.gov/pubmed/37904707
http://dx.doi.org/10.1002/iid3.1022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571499/
https://www.ncbi.nlm.nih.gov/pubmed/37904707
http://dx.doi.org/10.1002/iid3.1022

Ejemplares similares